|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
TuesdayTeva finds generic Copaxone less effective.Teva president of global R&D and chief scientific officer Dr. Michael Hayden said, "The data from this paper shows the possible significant ramifications of changes in physiochemical properties between Copaxone and a purported generic GA. READ MORE |